OBJECTIVE: To evaluate the role of copy number abnormalities detectable using chromosomal microarray (CMA) testing in patients with epilepsy at a tertiary care center. METHODS: We identified patients with International Classification of Diseases, ninth revision (ICD-9) codes for epilepsy or seizures and clinical CMA testing performed between October 2006 and February 2011 at Boston Children's Hospital. We reviewed medical records and included patients who met criteria for epilepsy. We phenotypically characterized patients with epilepsy-associated abnormalities on CMA. RESULTS: Of 973 patients who had CMA and ICD-9 codes for epilepsy or seizures, 805 patients satisfied criteria for epilepsy. We observed 437 copy number variants (CNVs) in 323 patients (1-4 per patient), including 185 (42%) deletions and 252 (58%) duplications. Forty (9%) were confirmed de novo, 186 (43%) were inherited, and parental data were unavailable for 211 (48%). Excluding full chromosome trisomies, CNV size ranged from 18kb to 142Mb, and 34% were >500kb. In at least 40 cases (5%), the epilepsy phenotype was explained by a CNV, including 29 patients with epilepsy-associated syndromes and 11 with likely disease-associated CNVs involving epilepsy genes or "hotspots." We observed numerous recurrent CNVs including 10 involving loss or gain of Xp22.31, a region described in patients with and without epilepsy. INTERPRETATION: Copy number abnormalities play an important role in patients with epilepsy. Because the diagnostic yield of CMA for epilepsy patients is similar to the yield in autism spectrum disorders and in prenatal diagnosis, for which published guidelines recommend testing with CMA, we recommend the implementation of CMA in the evaluation of unexplained epilepsy.
OBJECTIVE: To evaluate the role of copy number abnormalities detectable using chromosomal microarray (CMA) testing in patients with epilepsy at a tertiary care center. METHODS: We identified patients with International Classification of Diseases, ninth revision (ICD-9) codes for epilepsy or seizures and clinical CMA testing performed between October 2006 and February 2011 at Boston Children's Hospital. We reviewed medical records and included patients who met criteria for epilepsy. We phenotypically characterized patients with epilepsy-associated abnormalities on CMA. RESULTS: Of 973 patients who had CMA and ICD-9 codes for epilepsy or seizures, 805 patients satisfied criteria for epilepsy. We observed 437 copy number variants (CNVs) in 323 patients (1-4 per patient), including 185 (42%) deletions and 252 (58%) duplications. Forty (9%) were confirmed de novo, 186 (43%) were inherited, and parental data were unavailable for 211 (48%). Excluding full chromosome trisomies, CNV size ranged from 18kb to 142Mb, and 34% were >500kb. In at least 40 cases (5%), the epilepsy phenotype was explained by a CNV, including 29 patients with epilepsy-associated syndromes and 11 with likely disease-associated CNVs involving epilepsy genes or "hotspots." We observed numerous recurrent CNVs including 10 involving loss or gain of Xp22.31, a region described in patients with and without epilepsy. INTERPRETATION:Copy number abnormalities play an important role in patients with epilepsy. Because the diagnostic yield of CMA for epilepsypatients is similar to the yield in autism spectrum disorders and in prenatal diagnosis, for which published guidelines recommend testing with CMA, we recommend the implementation of CMA in the evaluation of unexplained epilepsy.
Authors: H Kurahashi; J-w Wang; A Ishii; T Kojima; S Wakai; T Kizawa; Y Fujimoto; K Kikkawa; K Yoshimura; T Inoue; S Yasumoto; A Ogawa; S Kaneko; S Hirose Journal: Neurology Date: 2009-10-13 Impact factor: 9.910
Authors: Feng Li; Yiping Shen; Udo Köhler; Freddie H Sharkey; Deepa Menon; Laurence Coulleaux; Valérie Malan; Marlène Rio; Dominic J McMullan; H Cox; Kerry A Fagan; Lorraine Gaunt; Kay Metcalfe; Uwe Heinrich; Gordon Hislop; Una Maye; Maxine Sutcliffe; Bai-Lin Wu; Brian D Thiel; Surabhi Mulchandani; Laura K Conlin; Nancy B Spinner; Kathleen M Murphy; Denise A S Batista Journal: Eur J Med Genet Date: 2010-02-02 Impact factor: 2.708
Authors: Leanne M Dibbens; Saul Mullen; Ingo Helbig; Heather C Mefford; Marta A Bayly; Susannah Bellows; Costin Leu; Holger Trucks; Tanja Obermeier; Michael Wittig; Andre Franke; Hande Caglayan; Zuhal Yapici; Thomas Sander; Evan E Eichler; Ingrid E Scheffer; John C Mulley; Samuel F Berkovic Journal: Hum Mol Genet Date: 2009-07-10 Impact factor: 6.150
Authors: Erin L Heinzen; Rodney A Radtke; Thomas J Urban; Gianpiero L Cavalleri; Chantal Depondt; Anna C Need; Nicole M Walley; Paola Nicoletti; Dongliang Ge; Claudia B Catarino; John S Duncan; Dalia Kasperaviciūte; Sarah K Tate; Luis O Caboclo; Josemir W Sander; Lisa Clayton; Kristen N Linney; Kevin V Shianna; Curtis E Gumbs; Jason Smith; Kenneth D Cronin; Jessica M Maia; Colin P Doherty; Massimo Pandolfo; David Leppert; Lefkos T Middleton; Rachel A Gibson; Michael R Johnson; Paul M Matthews; David Hosford; Reetta Kälviäinen; Kai Eriksson; Anne-Mari Kantanen; Thomas Dorn; Jörg Hansen; Günter Krämer; Bernhard J Steinhoff; Heinz-Gregor Wieser; Dominik Zumsteg; Marcos Ortega; Nicholas W Wood; Julie Huxley-Jones; Mohamad Mikati; William B Gallentine; Aatif M Husain; Patrick G Buckley; Ray L Stallings; Mihai V Podgoreanu; Norman Delanty; Sanjay M Sisodiya; David B Goldstein Journal: Am J Hum Genet Date: 2010-04-15 Impact factor: 11.025
Authors: Marwan Shinawi; Ankita Patel; Prisana Panichkul; Roxanne Zascavage; Sarika U Peters; Fernando Scaglia Journal: Am J Med Genet A Date: 2009-06 Impact factor: 2.802
Authors: Agatino Battaglia; Viola Doccini; Laura Bernardini; Antonio Novelli; Sara Loddo; Anna Capalbo; Tiziana Filippi; John C Carey Journal: Eur J Paediatr Neurol Date: 2013-05-24 Impact factor: 3.140
Authors: Carolien G F de Kovel; Holger Trucks; Ingo Helbig; Heather C Mefford; Carl Baker; Costin Leu; Christian Kluck; Hiltrud Muhle; Sarah von Spiczak; Philipp Ostertag; Tanja Obermeier; Ailing A Kleefuss-Lie; Kerstin Hallmann; Michael Steffens; Verena Gaus; Karl M Klein; Hajo M Hamer; Felix Rosenow; Eva H Brilstra; Dorothée Kasteleijn-Nolst Trenité; Marielle E M Swinkels; Yvonne G Weber; Iris Unterberger; Fritz Zimprich; Lydia Urak; Martha Feucht; Karoline Fuchs; Rikke S Møller; Helle Hjalgrim; Peter De Jonghe; Arvid Suls; Ina-Maria Rückert; Heinz-Erich Wichmann; Andre Franke; Stefan Schreiber; Peter Nürnberg; Christian E Elger; Holger Lerche; Ulrich Stephani; Bobby P C Koeleman; Dick Lindhout; Evan E Eichler; Thomas Sander Journal: Brain Date: 2009-10-20 Impact factor: 13.501
Authors: Marwan Shinawi; Pengfei Liu; Sung-Hae L Kang; Joseph Shen; John W Belmont; Daryl A Scott; Frank J Probst; William J Craigen; Brett H Graham; Amber Pursley; Gary Clark; Jennifer Lee; Monica Proud; Amber Stocco; Diana L Rodriguez; Beth A Kozel; Steven Sparagana; Elizabeth R Roeder; Susan G McGrew; Thaddeus W Kurczynski; Leslie J Allison; Stephen Amato; Sarah Savage; Ankita Patel; Pawel Stankiewicz; Arthur L Beaudet; Sau Wai Cheung; James R Lupski Journal: J Med Genet Date: 2009-11-12 Impact factor: 6.318
Authors: Yiping Shen; Kira A Dies; Ingrid A Holm; Carolyn Bridgemohan; Magdi M Sobeih; Elizabeth B Caronna; Karen J Miller; Jean A Frazier; Iris Silverstein; Jonathan Picker; Laura Weissman; Peter Raffalli; Shafali Jeste; Laurie A Demmer; Heather K Peters; Stephanie J Brewster; Sara J Kowalczyk; Beth Rosen-Sheidley; Caroline McGowan; Andrew W Duda; Sharyn A Lincoln; Kathryn R Lowe; Alison Schonwald; Michael Robbins; Fuki Hisama; Robert Wolff; Ronald Becker; Ramzi Nasir; David K Urion; Jeff M Milunsky; Leonard Rappaport; James F Gusella; Christopher A Walsh; Bai-Lin Wu; David T Miller Journal: Pediatrics Date: 2010-03-15 Impact factor: 7.124
Authors: F D Hannes; A J Sharp; H C Mefford; T de Ravel; C A Ruivenkamp; M H Breuning; J-P Fryns; K Devriendt; G Van Buggenhout; A Vogels; H Stewart; R C Hennekam; G M Cooper; R Regan; S J L Knight; E E Eichler; J R Vermeesch Journal: J Med Genet Date: 2008-06-11 Impact factor: 6.318
Authors: Heather E Olson; Nolwenn Jean-Marçais; Edward Yang; Delphine Heron; Katrina Tatton-Brown; Paul A van der Zwaag; Emilia K Bijlsma; Bryan L Krock; E Backer; Erik-Jan Kamsteeg; Margje Sinnema; Margot R F Reijnders; David Bearden; Amber Begtrup; Aida Telegrafi; Roelineke J Lunsing; Lydie Burglen; Gaetan Lesca; Megan T Cho; Lacey A Smith; Beth R Sheidley; Christelle Moufawad El Achkar; Phillip L Pearl; Annapurna Poduri; Cara M Skraban; Jennifer Tarpinian; Addie I Nesbitt; Dietje E Fransen van de Putte; Claudia A L Ruivenkamp; Patrick Rump; Nicolas Chatron; Isabelle Sabatier; Julitta De Bellescize; Laurent Guibaud; David A Sweetser; Jessica L Waxler; Klaas J Wierenga; Jean Donadieu; Vinodh Narayanan; Keri M Ramsey; Caroline Nava; Jean-Baptiste Rivière; Antonio Vitobello; Frédéric Tran Mau-Them; Christophe Philippe; Ange-Line Bruel; Yannis Duffourd; Laurel Thomas; Stefan H Lelieveld; Janneke Schuurs-Hoeijmakers; Han G Brunner; Boris Keren; Julien Thevenon; Laurence Faivre; Gary Thomas; Christel Thauvin-Robinet Journal: Am J Hum Genet Date: 2018-04-12 Impact factor: 11.025
Authors: Christelle M El Achkar; Heather E Olson; Annapurna Poduri; Phillip L Pearl Journal: Curr Neurol Neurosci Rep Date: 2015-07 Impact factor: 5.081
Authors: Wei-Chun J Hsu; Norelle C Wildburger; Sigmund J Haidacher; Miroslav N Nenov; Oluwarotimi Folorunso; Aditya K Singh; Brent C Chesson; Whitney F Franklin; Ibdanelo Cortez; Rovshan G Sadygov; Kelly T Dineley; Jay S Rudra; Giulio Taglialatela; Cheryl F Lichti; Larry Denner; Fernanda Laezza Journal: Exp Neurol Date: 2017-05-15 Impact factor: 5.330